A Dose-Finding and Efficacy Study of Venetoclax, CC-486, and Obinutuzumab in Follicular Lymphoma
Clinical trial NCT04722601 · TERMINATED
Trial details
- NCT number
- NCT04722601
- Sponsor
- University of Chicago
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-01
- Primary completion
- 2023-03-31
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.